chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I started a period two months after the 2nd vaccination. I started bleeding very heavily and passing clots. And never stopped until the 1st week in September. It was continuous. I was having severe panic attacks. I could not function throughout the day and they thought I was perhaps menopausal. They did hormone studies and that indicated that I was not close to being menopausal. They also did ultrasounds and found ovarian cysts that were not anything to be concerned about. They also did an endometrial biopsy which was negative. STD panel which was also negative. They had to increase my blood pressure medication to 30mg because my BP was up as well. They started me on Prempro medication because bleeding never stopped, and it was that heavy. She also gave me a prescription for Alprazolam which helped me calm down significantly. After the first month and a half, sometime mid to late August, I started to feel a little better and was able to function throughout the day. The first week in September was the first time I stopped bleeding. After that, my daughter tested positive for COVID in October, and it was two weeks after she initially gotten sick where I started bleeding extremely heavy with lots of clots and that lasted for over 30 days. I did notice the anxiety and the panic attacks, but I was able to manage that. The bleeding just never stopped. During those 3 initial months where I was bleeding as well, I was unable to eat and had no appetite. I could not eat anything so I only drank ice water and was constantly nauseated. I lost 20 lbs in one month. No I'm not bleeding or having symptoms anymore, unsure if this will happen again in the future ER visit was because of headache & panic attack.
Heart palpitations - first noticed around 26 hours after vaccine administration. Heart palpitations continue sporadically to today (day 3 post vaccine administration). Also, pain, swelling, itching, redness at injection site - resolved within 3 days.
Fever (Tmax 101.3F), Acetaminophen 500mg prn, resolved in 24 hours Muscle and joint pain, no treatment, resolved in 24 hours
itching; hive rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE URTICARIA (hive rash at injection site) and VACCINATION SITE PRURITUS (itching) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044321A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy, Drug allergy (Codeine, Sulfa drug allergy) and Adhesive tape allergy (Mastisol adhesive allergy). Concomitant products included LOSARTAN, ATORVASTATIN, TRAMADOL, TRAZODONE and SERTRALINE for an unknown indication.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, the patient experienced VACCINATION SITE URTICARIA (hive rash at injection site). On 19-Apr-2021 at 4:00 PM, the patient experienced VACCINATION SITE PRURITUS (itching). At the time of the report, VACCINATION SITE URTICARIA (hive rash at injection site) and VACCINATION SITE PRURITUS (itching) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
swollen; extremely itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swollen) and VACCINATION SITE PRURITUS (extremely itchy) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Concurrent medical conditions included No adverse event (No reported medical history).    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 22-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE SWELLING (swollen) and VACCINATION SITE PRURITUS (extremely itchy). At the time of the report, VACCINATION SITE SWELLING (swollen) and VACCINATION SITE PRURITUS (extremely itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.  Based on the current available information and the temporal association between the product use and the start date of the evens a causal relationship cannot be excluded.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and the temporal association between the product use and the start date of the evens a causal relationship cannot be excluded.
Vacine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vacine exposure during pregnancy) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 029L20A) for COVID-19 immunisation.     No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 28-Aug-2021. On 12-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vacine exposure during pregnancy). On 09-Feb-2021, EXPOSURE DURING PREGNANCY (Vacine exposure during pregnancy) had resolved.            Concomitant medication was not reported. Treatment medication was not reported.
mother states child has been doing well until about 11-11:30 a.m. on 9/27.  Had been a little fussy since 7 a.m. crying - at about 11-11:30 noticed right upper thigh swelling and redness about 3 inches across.  Had not noticed this earlier today.  Mother instructed to contact her physician - in meantime try covered ice pack on 20 min off 20 min and continue with tylenol for age 9/28/07 site of Prevnar remains red and swollen 10/01/07 child ok - still slightly red
lightheaded, throat swollen Narrative: Pt experience lightheadedness and felt throat swelling starting 5 minutes after receiving first covid vaccine, leading to ED visit. Given epi and IM diphenhydramine.
Approximately on January 13, 2022 I experienced the following symptoms: I had a hive breakout (specifically in the waist line, arm pit, groin area) and then went on for the next couple of days it became itchy. Anytime I play with my dog or something would touch my skin it would develop into some kind of rash. I started taking Zyrtec (1x/day) and it did reduce the itching but the bumps/rash would still be visible. I consulted with a health practitioner (General consultation) and was recommended taking Zyrtec. Up to this day 02/25/2022 the itchiness has already subsided but the rash still comes every now and then.
reported swelling from elbow to shoulder.  Hot and hard to touch.  symptoms resolving with time.
pt noted to have erythema & hives around inj site;ice was applied as swell as DPH;pt did not require admission;
kidney pain which has worsened; cough; tested negative for COVID; This spontaneous case was reported by a consumer and describes the occurrence of RENAL PAIN (kidney pain which has worsened), COUGH (cough) and SARS-COV-2 TEST NEGATIVE (tested negative for COVID) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     Concurrent medical conditions included Kidney pain (kidney pain which has worsened from past 2 weeks.).    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced RENAL PAIN (kidney pain which has worsened), COUGH (cough) and SARS-COV-2 TEST NEGATIVE (tested negative for COVID). At the time of the report, RENAL PAIN (kidney pain which has worsened), COUGH (cough) and SARS-COV-2 TEST NEGATIVE (tested negative for COVID) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: TCR added.
PATIENT HAD J&J VACCINE ON 03/27/2021, AND TESTED POSITIVE TO COVID
Patient started noticing soreness in left arm the evening after receiving the vaccine. 12/01/15 redness, soreness, and swelling noted. 12/02/15 worsening redness, swelling, and pain accompanied with numbness in left hand. Right arm also noted to have a small red swollen area about 3 inches below deltoid injection site. Patient denies pain the that arm.
Pt received vaccine 9/2/10. On 9/3/10 cried in pain, said it was stinging, swollen, red. Mom called office instructed to give TYLENOL or MOTRIN for pain, warm or cool compresses to site. Later that day, pt developed hives down leg injection was given to. Pt. refused to use leg. Mom started Epsom salt baths. Pt improved to limping x 3 days. Mom followed up on 9/7/10. Pt leg swollen @ injection site has no redness, warmth, or D/C.
33M with pmh GERD, no known hx allergies, p/w sob after receiving IM epi at clinic. Pt received covid vaccine and was having anxiety - told the provider she was SOB so she was given epi and started having more anxiety so she was brought to the ED. Upon arrival, patient agitated tachy to 120s, screaming, flailing her arms,
4/28/21 Pt presented to the ED with complaints of a cough that started 2 weeks ago and was getting worse and weakness with several falls. She also admitted to intermittent diarrhea. She was found to be febrile with a temp to 101.1, tachypneic w/RR of 20. Sats were in the low 90's. NP was was positive for SARS-CoV-2. CXR showed bilateral opacities and she was admitted for PNA and sepsi. She was given Rocephin and Z-max in ED and both were discontinued upon admission. She was started on Decadron in ED  4/30 she had increasing hypoxemia and was placed on a non rebreather. She was transferred to critical care and given tocilizumab. Her respiratory status continued to worsen and she was intubated. She subsequently developed a pneumothorax that persisted despite 2 chest tubes. She developed a large air leak and she was not a surgical candidate. Family ultimately decided to w/draw care on 5/15/21
joint aches initially and then severe headache with a slight fever that lasted at lest 4 hours. Patient took an ibuprofen around 10 pm and finally fell asleep around 1 am.  During the next day she had intermittent headaches and had sore joints.
The patient was mistakenly administered the covid (Moderna) vaccine.  She had 2 doses of covid (Pfizer) vaccine, previously.  She got both FluzoneHD and the covid (Moderna) vaccine on 9/10/21.
Patient experienced flushing, tingling in toes, pounding heart, and elevated BP of 142/80. Patient observed, and symptoms resolved without medication.
Information has been received from a physician concerning a 17 year old female who was vaccinated with a first dose of GARDASIL. Subsequently the patient passed out immediately after receiving the vaccination. The patient remained unconscious for approximately thirty seconds. On approximately 17-SEP-2007 she was vaccinated with a second dose of GARDASIL. On approximately 17-SEP-2007 approximately three minutes after vaccination, the patient called out for her mother, started humming, and then passed out. She remained unconscious for approximately thirty seconds. The patient reported that her experience after the second dose of GARDASIL was "different" from the first dose. The patient was being referred to a neurologist. Unspecified medical attention was sought. At the time of the report the patient had recovered. Additional information has been requested.
Generalized weakness, unable to walk.  Chills.  Temp 99.4 Admitted to hospital given IV saline and supportive care.  Discharge on second day.
Pain in lymph nodes; nausea; pain in ovary-area; perhaps linked to inflammation and PCOS flare up with vaccination; perhaps linked to inflammation and PCOS flare up with vaccination; perhaps linked to inflammation and PCOS flare up with vaccination; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 28 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 04Nov2021 17:30 (Batch/Lot number: unknown) at the age of 28 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Depression" (unspecified if ongoing); "known allergies: Latex" (unspecified if ongoing); "anxiety" (unspecified if ongoing); "PCOS" (unspecified if ongoing). Concomitant medication(s) included: LORATADINE; PAXIL [PIROXICAM]. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Card with info not on me at this time), administration date: 15Jan2021, when the patient was 27 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 2, Batch/Lot No: Unknown. Card not available at this time , Location of injection: Arm Right), administration date: 2021, for COVID-19 immunization. The following information was reported: LYMPH NODE PAIN (non-serious) with onset 05Nov2021, outcome "not recovered", described as "Pain in lymph nodes"; NAUSEA (non-serious) with onset 05Nov2021, outcome "not recovered", described as "nausea"; ADNEXA UTERI PAIN (non-serious) with onset 05Nov2021, outcome "not recovered", described as "pain in ovary-area"; INFLAMMATION (non-serious), POLYCYSTIC OVARIES (non-serious), CONDITION AGGRAVATED (non-serious) all with onset 05Nov2021, outcome "not recovered" and all described as "perhaps linked to inflammation and PCOS flare up with vaccination". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of lymph node pain, nausea, adnexa uteri pain, inflammation, polycystic ovaries, condition aggravated.  Additional information- It was reported that Facility where the most recent COVID-19 vaccine was administered: Nursing Home,Senior Living Facility.The patient did not  receive any other vaccines within 4 weeks prior to the COVID vaccine.Prior to vaccination,  the patient  was not diagnosed with COVID-19 and Since the vaccination,  the patient had  been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Seen 11/30/10, received pneumonia vaccine, had stated she received at some point in past but didn't know when, seen 12/1/10, she had fallen during the night,  fell in (L) arm, had been started on LEXAPRO visit prior and Z-PAK for sinus, was dizzy. Noted next AM (L) arm red, slightly swollen & warm, 3-4" below injection site.
Tinnitus (still after several months), also daily headache several weeks after injection and dizziness a couple of weeks after. Headache and dizziness now gone but tinnitus still left. Have visited a doctor but didnt get any answers.
Within 90 days of receiving vaccine, (April 02,2021) I experienced Atrial Fibrillation.  Heart rate approached 160bpm, and was admitted to the ER.  I did get lucky and cardioverted on my own, but now I'm on new heart medications (metoprolol) and have had to adjust my lifestyle.
Rash-shot given 1/21/08, rash on 2/3/08 otherwise no symptoms.
2/24 -Facial redness, minor swelling, nose peeling.  2/25 -Hands dark red, forearms red raised rash, hives on upper chest. 2/26- hands very swollen, almost had to cut ring off, rash progress to upper chest, hives resolve 2/27-3/4- rash continues, itching, face looks better, rash starting on lower legs with pitting edema 3/4-3/12- Rash less red on body and starting to dry up, face resolved, rash still on neck, legs improved, extremely dry and scaly skin on hands and forearms, still red patches on hands and neck, starting to peel skin on finger tips.  much improved at this time but not back to normal yet. Never had a fever, cold symptoms, difficulty breathing or any other symptoms. Tried treatment with Benadryl and hydrochloride cream but no improvements.
Mild tar dive dyskinesia for 24 hours; This is a spontaneous report from a contactable consumer (reported for herself). A 65-years-old female patient received second dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: Pfizer EM 6199) administered at left arm via an unknown route of administration on 03Mar2021 13:30 as single dose for COVID-19 immunization. Medical history included Major unipolar depression. The patient was previously administered first dose of the vaccine (lot number: Pfizer EM 9809) on 10Feb2021 13:00, administered on left arm as single dose and experienced no adverse event. Concomitant medications included phenelzine sulfate (NARDIL) within 2 weeks of vaccination (15mg) 4 times daily and other vaccines on 03Mar2021. On 03Mar2021 at 15:00pm, the patient experienced mild tar dive dyskinesia for 24 hours. The outcome of the event was recovered with sequelae. Device date reported as 25Apr2021. The patient has not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient has not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  Additional Information has been requested.
Large erythematous zone and drainage at vaccination site. Satellite lesions on upper trunk from top of head to waist. Fever and flu like symptoms.
4.5 cm area of erythema on thigh 24 hrs after injections.No respiratory symptoms.
This spontaneous report as received from a registered nurse refers to a multiple unspecified patients of unknown age and unknown gender. There was no information abut concurrent condition, medical history or concomitant medication. On an unknown date, the patients were vaccinated with unspecified doses of improperly stored PNEUMVOVAX 23 (lot # L019835 and expiry date 23-MAR-2017) (dosing details unspecified) (also reported nurse was unsure of which vaccine was administered). No adverse effects were reported. No Product Quality Complaint (PQC) was involved. Details of temperature excursion: Temperature: 64.9F. Time frame: 4 hours and 19 minutes. Previous temperature excursion: No. Data logger: Yes. This is one of the several reports received from the same reporter. Additional information has been requested.
pt recv vax SEP98 & approx 2wk post vax pt exp elevated LFT's;
fatigue; fever; chills; This is a spontaneous report from a contactable consumer (patient) reported for self. A 71-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6208), via an unspecified route of administration, administered in arm left on 16Mar2021 at 12:00 (at the age 71-year-old) as dose 1, single, and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0151), via an unspecified route of administration, administered in arm left on 08Apr2021 12:00 (at the age 71-year-old) as dose 1, single for COVID-19 immunization (Hospital). Medical history included COVID-19 in mid Dec2020. Patient had no known allergies. Concomitant medications included simvastatin; and hydrochlorothiazide, triamterene (TRIAMTERENE/HCTZ). Patient had covid prior vaccination. Patient had not been covid tested post vaccination. Patient has not received any other vaccines in four weeks. On 12Apr2021 at 12:00, the patient experienced fatigue, fever, and chills. It was reported that approximately 4 days after both inoculations patient experienced events which were very similar to symptoms while suffering from COVID-19. Therapeutic measures were taken as a result of events included Ibuprofen, Tylenol. The outcome of the events was recovered on an unknown date in 2021.  No follow-up attempts are possible. No further information is expected.
Body hurts; Lot of itching on body; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Aug2021 at 09:00 (at the age of 26-years-old), as a single dose for COVID-19 immunisation. Medical history included gallbladder and appendix removed and had a biopsy when patient was a year old to check out liver in 1996 (liver biopsy in 1996). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously took paracetamol (TYLENOL) for unspecified indication from unknown date and experienced drug allergy. On 07Aug2021 at 12:00, the patient's body hurt and had a lot of itching on body. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events body hurt and lot of itching on body was not recovered at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
fever about 2 hrs p/vax; went to 101; started w/shrill hurt cry then lasted 5 dasy; slept only 45 mins @ time; APAP helped; the cry was more then fussy as if in pain;
Flu shot October - 2007. March - 2008 - The arm where I got my shot was red and itch. 3" in dia for 2 weeks. There were 2 days I felt like flu. But no temp. 2 weeks after I came down with Bronchitis and Penomia. A very severe cough. I might not get the flu shot in 2008. 5/28/08 - Feel congested yet my nose feels stuffy.
Dose administered to 26 patients from 5 vials stored in the fridge for more than 30 days; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to 26 patients from 5 vials stored in the fridge for more than 30 days) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033H21A) for COVID-19 vaccination.     Concurrent medical conditions included HIV disease, Drug allergy (Abacavir), Drug allergy (Lamivudine), Allergy to antibiotic (Sulfamethoxazole), Allergy to antibiotic (Trimethoprim), Drug allergy (Zidovudine), Allergy to antibiotic (Dapson) and Drug allergy (Neviarpine). Concomitant products included COBICISTAT, ELVITEGRAVIR, EMTRICITABINE, TENOFOVIR ALAFENAMIDE FUMARATE (GENVOYA) and ROSUVASTATIN for an unknown indication.    On 31-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to 26 patients from 5 vials stored in the fridge for more than 30 days). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to 26 patients from 5 vials stored in the fridge for more than 30 days) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Vials were moved to fridge on 28-Dec-2021 for 30 day expiration of 27-Jan-2022. Other vaccination dates were 04-May-2021 and  01-Jun-2021.  The patient was on ongoing medications for HIV disease.  No Treatment medications were reported.
Swelling, redness, pain of left thigh at injection site; used ibuprofen and ice with minimal relief.